홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Epigallocatechin Gallate → (3,4,5-Trihydroxy-6-oxo-6h-benzo[7]annulene-1,8-diyl)bis[(2r,3r)-5,7-dihydroxy-3,4-dihydro-2h-chromene-2,3-diyl] bis(3,4,5-trihydroxybenzoate)

HRID 1182431
인쇄

반응식

HRID 1182431 반응식
[CH2:1]1[C:10]2[C:5](=[CH:6][C:7]([OH:12])=[CH:8][C:9]=2[OH:11])[O:4][C@H:3]([C:13]2[CH:20]=[C:19]3[C:21]([C@@H:27]4[O:36][C:35]5[C:30](=[C:31]([OH:38])[CH:32]=[C:33]([OH:37])[CH:34]=5)[CH2:29][C@@H:28]4[O:39][C:40]([C:42]4[CH:47]=[C:46]([OH:48])[C:45]([OH:49])=[C:44]([OH:50])[CH:43]=4)=[O:41])=[CH:22][C:23]([OH:26])=[C:24]([OH:25])[C:18]3=[C:17]([OH:51])[C:15](=[O:16])[CH:14]=2)[C@@H:2]1[OH:52].[CH2:53]1[C:62]2[C:57](=[CH:58][C:59]([OH:64])=[CH:60][C:61]=2[OH:63])[O:56][C@H:55]([C:65]2[CH:70]=[C:69](O)[C:68]([OH:72])=[C:67]([OH:73])[CH:66]=2)[C@@H:54]1[O:74][C:75]([C:77]1[CH:82]=[C:81]([OH:83])[C:80]([OH:84])=[C:79]([OH:85])[CH:78]=1)=[O:76]>>[CH2:1]1[C:10]2[C:5](=[CH:6][C:7]([OH:12])=[CH:8][C:9]=2[OH:11])[O:4][C@@H:3]([C:13]2[C:20]3[C:18](=[C:24]([OH:25])[C:23]([CH:22]=[C:21]([C@H:27]4[O:36][C:35]5[C:30](=[C:31]([OH:38])[CH:32]=[C:33]([OH:37])[CH:34]=5)[CH2:29][C@H:28]4[O:39][C:40]([C:42]4[CH:43]=[C:44]([OH:50])[C:45]([OH:49])=[C:46]([OH:48])[CH:47]=4)=[O:41])[CH:19]=3)=[O:26])[C:17]([OH:51])=[C:15]([OH:16])[CH:14]=2)[C@H:2]1[OH:52].[CH2:29]1[C:30]2[C:35](=[CH:34][C:33]([OH:37])=[CH:32][C:31]=2[OH:38])[O:36][C@H:27]([C:21]2[CH:19]=[C:70]3[C:65]([C@H:55]4[O:56][C:57]5[C:62](=[C:61]([OH:63])[CH:60]=[C:59]([OH:64])[CH:58]=5)[CH2:53][C@H:54]4[O:74][C:75]([C:77]4[CH:82]=[C:81]([OH:83])[C:80]([OH:84])=[C:79]([OH:85])[CH:78]=4)=[O:76])=[CH:66][C:67]([OH:73])=[C:68]([OH:72])[C:69]3=[C:24]([OH:25])[C:23](=[O:26])[CH:22]=2)[C@@H:28]1[O:39][C:40]([C:42]1[CH:43]=[C:44]([OH:50])[C:45]([OH:49])=[C:46]([OH:48])[CH:47]=1)=[O:41]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 65064Epigallocatechin Gallate2회HCID 102115506[(2S,3S)-5,7-dihydroxy-2-[3,4,5-trihydroxy-6-oxo-8-[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-1-yl]-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate

생성물 2

HCID 467320(3,4,5-Trihydroxy-6-oxo-6h-benzo[7]annulene-1,8-diyl)bis[(2r,3r)-5,7-dihydroxy-3,4-dihydro-2h-chromene-2,3-diyl] bis(3,4,5-trihydroxybenzoate)
HCID 102115505
Tragopogonic acid

실험 절차

EC (1 g, 3.5 mmol) and EGC (1 g, 3.3 mmol) were dissolved into the 200 mL of phosphate-citrate buffer (50 mM, pH 5.0) along with 2 g of crude PPO enzyme. The enzymatic oxidation was carried out at room temperature for 6 hour with stirring. The reaction solution was then subjected to fractionation with the same volume of ethyl acetate with three times. Then, the organic layer was concentrated under reduced pressure. The resulting residues were subjected to Sephadex LH-20 column chromatography eluting with gradient of ethanol to 20% of acetone in ethanol. Among the collected 14 fractions (each c.a. 90 mL), 8˜10 fractions were combined, and concentrated under reduced pressure. The resulting residue was subjected to further purification on a RP-18 silica gel column eluting with gradient of 40%˜50% of aqueous methanol. During elution, 38 fractions (each c.a. 13 mL) were received. Among them, 10˜17 fractions were combined, and concentrated under reduced pressure, and were subjected to freeze-drying. It yielded deep-reddish color of compound 1 (280 mg). Along with the same enzyme reaction and isolation procedure, compound 2 was obtained from EC and EGCG reaction. The enzymatic oxidation of EGC and ECG, ECG and EGCG reaction yielded compound 3 and compound 4, respectively.

출처 및 근거

ORD 기록
ord-1c32443a2f8c45d9a434a69c5701bc79
출처 데이터셋
uspto-grants-2007_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07288680B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트